200 mg Soranib Sorafenib Tablets

Soranib 200 mg (Sorafenib) is a targeted anti-cancer medication (multikinase inhibitor) manufactured by Cipla. It is prescribed for advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and certain types of thyroid cancer. It works by blocking specific proteins that cause cancer cells to multiply and slowing the formation of new tumor blood vessels.

liketo.usa,uk,china,southkorea,russia,japan,singapore